Anna Sumeray

UBS Securities LLC is an investment bank and registered broker/dealer headquartered in New York City. The firm was founded in 1998 as UBS Warburg LLC. They are a subsidiary of UBS Americas Holding LLC, ultimately held by UBS Group AG (SWX: UBSG, NYSE: UBS) in Switzerland. UBS Securities is a primary dealer in US Government securities and provides a full range of investment banking services which includes corporate finance, mergers and acquisitions, capital markets, trading and sales, fixed-income, equity research, private banking, underwriting and prime brokerage operations. The firm also provides advisory services and access to capital markets for corporate, institutional, intermediary and alternative asset management clients.

Else Kröner-Fresenius-Stiftung engages in the promotion and development of medical research and medical-humanitarian projects. It focuses on the study in the causes, diagnosis, and therapy of diseases. The company was founded by Else Kröner in 1983 and is headquartered in Bad Homburg, Germany.

Horizon Therapeutics Schweiz GmbH is a biopharmaceutical company that develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company was originally founded in 2004 as a spin-out of Merck KGaA and is headquartered in Reinach, Switzerland.

QIAGEN GmbH provides products for preanalytical sample preparation and molecular diagnostics solutions. It develops and markets consumable products and automated solutions to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control. The company was founded in 1984 and is headquartered in Hilden, Germany.

Janssen Vaccines & Prevention BV manufactures and supplies biopharmaceutical products. The company was founded in 2000 and is headquartered in Leiden, the Netherlands.

Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life.

Etna Biotech SRL provides bio-pharmaceutical research and develops vaccines. It engages in researching and developing vaccines and immunotherapeutics for infectious diseases and other chronic illnesses. The company was founded in 2001 and is headquartered in Catania, Italy.

Part of Wilh. Werhahn KG, HUMAN Gesellschaft für Biochemica und Diagnostica mbH is a healthcare company based in Wiesbaden, Germany. HUMAN has been serving the healthcare sector for 50 years with high-quality products, renowned services, and individualized support. With R&D and production anchored in and with partners in more than 160 countries, HUMAN is regarded as a player in the IVD industry. The German company's worldwide network of subsidiaries and distributors guarantees being close to the users, providing service and support. HUMAN offers a constant supply of products and support, and its customers' satisfaction is its success. The company was founded in 1972. Ralph Neuberger has been the CEO of the company since 2002.

BiognoSYS AG operates as a biotechnology company. Its products include iRT Kit, HRM Kit, Sample Prep Kit, PlasmaDive, Spectronaut and SpectroDive. The company was founded by Philipp M. Antoni, Johan Malmstroem and Oliver Rinner on September 3, 2008 and is headquartered in Schlieren, Switzerland.

Novaremed AG operates as a pharmaceutical company. It develops NEB74S, a molecule for the treatment of chronic pain. The company was founded by Eliahu Kaplan in 2008 and is headquartered in Petah Tikva, Israel.

Anokion SA provides technology for retraining white blood cells to induce therapeutic immune tolerance. The firm?s approach to antigen-specific immune tolerance can be translated to virtually any protein in numerous clinical indications. The company was founded by Jerffery Hubbell, Melody Swartz, Stephan Kontos, Oscar Buset, Kristen M. Lorentz and David A. Lowin and is headquartered in Ecublens, Switzerland.

INDICAL BIOSCIENCE GmbH provides solutions for molecular diagnostics for vet-specific applications. It offers diagnostics for better animal and human health. The company was founded in 1996 and is headquartered in Leipzig, Germany.

Kanyos Bio, Inc. engages in the provision of immune tolerance technology solutions. It develops antigen-specific for treatment of type-1 diabetes and celiac disease. The company was founded by Jeffrey Hubbell, Stephan Kontos, Oscar Buset, Kristen M. Lorentz, and David A. Lowin in 2015 and is headquartered in Cambridge, MA.

Part of AdhexPharma SAS, tesa Labtec GmbH is a German pharmaceutical company that manufactures pharmaceutical products. The company is based in Langenfeld, Germany. The company was founded in 1990 by Günter Cordes. The CEO is Detlev Radloff. tesa Labtec was acquired by AdhexPharma SAS from maxingvest AG on September 30, 2022.

Joint Polish Investment Fund Management BV (Joint Polish Investment Fund Management) is a venture capital firm founded in 2015. The firm headquartered in Netherlands.

Fondation De l'Hôpital Barrie Memorial is a private company based in Ormstown, Canada. The Canadian company engages in raising funds to improve health care and services.

HealthUp Sp zoo develops MySpiroo -a mobile spirometer, which is a handheld, portable, wireless, smartphone connected medical device. The company was founded on August 19, 2014 and is headquartered in Warsaw, Poland.

TOLREMO therapeutics AG engages in discovering and developing therapies for treating cancer patients. The firm serves on academic research laboratories, flourishing life sciences spin-offs and cutting-edge technology platforms. The company was founded by Stefanie Flückiger-Mangual, Wilhelm Krek, Karl-Heinz Altmann, Isaac Kobrin, and Emmanuel Savioz in March 2017 and is headquartered in Zurich, Switzerland.

Part of Affimed NV, Affimed GmbH is a clinical leader in innate immuno-oncology. The company, based in Heidelberg, Germany, develops proprietary cancer-targeting bispecific antibodies that activate the innate immune system to kill tumor cells. Affimed leads clinical development of innate cell engagers for solid/hematologic tumors as monotherapy, in combination with NK cells or with checkpoint inhibitors. Adolf Hoess has been the CEO of the German company since 2010.

NeraCare GmbH operates clinics. The company is based in Cologne, Germany. The German company was founded by Daniel von Janowski and Friedrich Ackermann. Daniel von Janowski has been the CEO since incorporation.

Indical Topco AB is a Swedish company that owns and manages shares, as well as real and movable properties. The private company is based in Stockholm, Sweden.

Avelo AG is a Swiss company that aims to save lives by providing fast and actionable infectious disease diagnosis closer to the patient. Avelo is based in Schlieren, CH. The company's solution is a breath collection device that works with existing molecular tests to detect multiple respiratory tract infections causing pneumonia. The company was founded in 2020 by Melanie Aregger and Tobias Broger, with Melanie Aregger serving as the CEO since 2020.